| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |